St. Michael's Foundation’s Post

#CaseOfTheDay : #VoteTheCorrectReaponse : A 35-year-old male presents to the emergency department with a rapidly progressive ascending symmetric flaccid paralysis requiring mechanical ventilation. One week ago, he experienced a mild respiratory infection. On examination, he is afebrile, has 3/5 motor strenth in his extremities and reveal decreased reflexes in the lower extremities. A lumbar puncture yields clear, colourless cerebrospinal fluid under normal pressure. The CSF report reveals albuminocytologic dissociation(= increased protein levels with normal leukocyte count < 10 cells/mcL in CSF). Question: Which of the following is the most likely diagnosis? A. Multiple Sclerosis B. Guillain-Barré Syndrome C. Myasthenia Gravis D. Amyotrophic Lateral Sclerosis (ALS) E. Poliomyelitis

Adults living with congenital heart disease face an increased risk of hospitalisation and mortality due to arrhythmia disorders. With improved surgical and medical techniques, more patients are surviving into adulthood - but complications like arrhythmias persist. Discover the intricacies of arrhythmia with EMJ this World Heart Rhythm Awareness week - act smart, you only have one heart: https://hubs.la/Q02zBCYt0 #WHRW2024 #ArrhythmiaAlliance #HeartHealth

Cardiovascular disease (CVD) remains the leading cause of death among men in the UK, accounting for around 25% of male deaths annually, according to the British Heart Foundation. Despite advances in treatment, prevention remains critical. Early detection and management can significantly improve outcomes, yet many men either do not recognise the signs of cardiovascular risk or are hesitant to seek medical advice. Book our expert-led cardiac health screening today: https://lnkd.in/eP7x88Bv #InternationalMensDay #CardiovascularDisease #CVD #UKStatistics #Healthcare #FastDiagnosis #PreventativeHealthcare #DiagnosticImaging #Diagnosis #EarlyDetection

Durable respiratory support as alternative to lung #transplantation for patients with chronic lung disease, review providing overview of recent advancements: 🫁 several ambulatory respiratory assist systems under development/preclinical investigation demonstrated favourable results + excellent biocompatibility & performance 🫁 currently, 2 ambulatory respiratory assist systems are clinically approved; early experiences have shown safety/efficacy, presenting viable alternative respiratory support strategy 🩸novel anticoagulation strategies under investigation to address artificial surface-induced thrombosis, minimizing bleeding risks ⚙️ innovative surface coatings are being explored to locally mitigate artificial surface-induced clot formation 🖇️ https://bit.ly/3WjI1Xo

September is Sepsis Awareness Month Sepsis affects millions of lives globally, requiring rapid intervention to prevent severe complications and death. Early detection and treatment are key to saving lives. Swipe through to discover important sepsis facts and how FloPatch is revolutionizing care with real-time insights for timely, effective treatment. Join us at the Sepsis Alliance Summit to learn how FloPatch is shaping the future of sepsis care. 🔗 Register and learn more here: https://hubs.ly/Q02PJ1d70 Sources: Rudd et al., The Global Burden of Sepsis, The Lancet Rhee et al., Sepsis in the US, JAMA Network Open Mayr et al., Sepsis Mortality and Costs, JAMA Torio et al., The Most Expensive Hospital Conditions, AHRQ #SepsisAwareness #SepsisAwarenessMonth #Sepsis #SepsisAlliance #WorldSepsisDay #FloPatch #FlosonicsMedical

Today is World Sepsis Day, a time to bring awareness to the #1 cause of death in hospitals. Sepsis is the body's extreme response to an infection and is a life-threatening medical emergency. Sepsis can rapidly lead to tissue damage, organ failure, and death without timely treatment. Health Information Alliance focuses on Sepsis studies to reduce life-threatening complications in hospitals and save lives. We are committed to helping hospitals mitigate risk through clinical studies. Together, we can shape a future where sepsis is preventable and manageable! #WorldSepsisDay #HIACares

September is World Sepsis’ Month, a chance to improve awareness of this life-threatening condition. Worldwide, one person dies from sepsis every 2.8 seconds. For those 11 million people each year, rapid recognition and treatment are crucial to their survival. This month, take time to understand sepsis. #Sepsis #ValueofDiagnostics #RocheFightsSepsis https://lnkd.in/gDUBrRBJ

🌍 Tackling the World's Leading Respiratory Threats with Innovation 💡 Did you know pneumonia is still the #1 infectious cause of death in children globally? And conditions like COVID-19 and Cystic Fibrosis continue to strain healthcare systems everywhere. Laboratorios Quimica Luar, are on a mission to change that. 🔬 An ibuprofen-based nebulized mist – a first-of-its-kind treatment that delivers medication directly to the lungs, offering a new, more effective solution for pediatric pneumonia, COVID-19, Cystic Fibrosis, and other complex respiratory conditions. 🌬️ Why is this a game-changer? - Direct lung delivery for faster, more targeted treatment 🚀 -A groundbreaking approach to treating conditions often left underserved 🌱 - A fresh, more accessible option for critical respiratory care #LaboratoriosQuimicaLuar #InnovationInHealthcare #RespiratoryTreatment #CysticFibrosis #COVID19Treatment #PneumoniaCare #MedTech #PharmaceuticalInnovation #IPStrategy #GlobalHealth #FutureOfMedicine

Sepsis kills more people than heart attacks and stroke combined and yet we have no dedicated in-hospital sepsis response teams. MI and stroke patients have a dedicated team that arrive at their bedside within minutes and sepsis does not. Also in need of out patient sepsis clinics that GP's can refer patients on to that are at higher risk of developing sepsis for closer monitoring. Time to invest in sepsis if we want to see results. #sepsis #prevention #notrocketscience #realaction #resources

🌟 QI Week - Exciting Update on Our Deteriorating Patients Programme! 🌟 🔍 Phase 2 Focus: Sepsis 🔍 Did you know that Sepsis affects at least 245,000 people in the UK each year, with up to 48,000 deaths annually? Those who survive often face life-changing after-effects. Sepsis is a severe response to infection that can cause organ dysfunction and claims more lives than many well-known diseases combined. Our Acute Areas are working together on improvements in training, communication and practice to ensure the early identification and treatment of sepsis to enhance patient outcomes. Teams are using the Sepsis Six Pathway to support the delivery of timely, life-saving care. Stay tuned as we continue to drive change and improve patient care across the Trust! 💙 #QualityCare #patientsafety #HealthcareExcellence #SepsisAwareness #continuousimprovement #teamwork Solent Academy of Research & Improvement